Introduction
The isolation and discovery of the antimalarial activity of artemisinin 1 represents one of the great events in medicine in the latter half of the 20th Century.
[1] Artemisinin and its derivatives dihydroartemisinin (DHA, 2), artesunate 3, and artemether 4 [2] [3] [4] are now widely used for treatment of malaria caused by the most virulent parasite, Plasmodium falciparum. [5] The pivotal problem in their use, that of a short pharmacological half-life, was uncovered by the Chinese and countered early on by administering artemisinin in combination with the pharmacologically robust mefloquine.
[6] Consequently, artemisinins are now routinely used in combination with longer half-life drugs, [7] and emphasis is now placed on the development of fixed combinations.
The results of Fe
2 + -induced decomposition of the clinically used artemisinins, artemisone, other aminoartemisinins, 10-deoxoartemisinin, and the 4-fluorophenyl derivative have been compared with their antimalarial activities and their ability to inhibit the parasite SERCA PfATP6. The clinical artemisinins and artemisone decompose under aqueous conditions to give mixtures of C radical marker products, carbonyl compounds, and reduction products. The 4-fluorophenyl derivative and aminoartemisinins tend to be inert to aqueous iron(II) sulfate and anhydrous iron(II) acetate. Anhydrous iron(II) bromide enhances formation of the carbonyl compounds and provides a deoxyglycal from DHA and enamines from the aminoartemisinins. Ascorbic acid (AA) accelerates the aqueous Fe 2 + -mediated decompositions, but does not alter product distribution. 4-Oxo-TEMPO intercepts C radicals from a mixture of an antimalaria-active trioxolane, 10-deoxoartemisinin, and anhydrous iron(II) acetate to give trapped products in 73 % yield from the trioxolane, and 3 % from the artemisinin. Artemisone provides a trapped product in 10 % yield. Thus, in line with its structural rigidity, only the trioxolane provides a C radical eminently suited for intermolecular trapping. In contrast, the structural flexibility of the C radicals from the artemisinins allows facile extrusion of Fe 2 + and collapse to benign isomerization products. The propensity towards the formation of radical marker products and intermolecular radical trapping have no relationship with the in vitro antimalarial activities of the artemisinins and trioxolane. Desferrioxamine (DFO) attenuates inhibition of PfATP6 by, and antagonizes antimalarial activity of, the aqueous Fe 2 + -susceptible artemisinins, but has no overt effect on the aqueous Fe 2 + -inert artemisinins. It is concluded that the C radicals cannot be responsible for antimalarial activity and that the Fe 2 + -susceptible artemisinins may be competitively decomposed in aqueous extra-and intracellular compartments by labile Fe 2 + , resulting in some attenuation of their antimalarial activities. Interpretations of the roles of DFO and AA in modulating antimalarial activities of the artemisinins, and a comparison with antimalarial properties of simple hydroperoxides and their behavior towards thapsigargin-sensitive SERCA ATPases are presented. The general basis for the exceptional antimalarial activities of artemisinins in relation to the intrinsic activity of the peroxide within the uniquely stressed environment of the malaria parasite is thereby adumbrated.
In contrast to the universal acceptance of the utility of artemisinins as the most potent and rapidly acting of all antimalarial drugs, a seemingly intractable controversy surrounds the manner in which these drugs are presumed to act as parasiticidal agents. It has been proposed that activity arises as a result of reductive or Fenton-like cleavage of the peroxide by Fe 2 + to generate alkoxyl radicals, which either abstract hydrogen atoms from the artemisinin periphery or undergo b-scission to provide carbon-centered radicals (C radicals) (Figure 1 ). The C radicals are held to alkylate proteins vital to parasite function. [8] [9] [10] [11] [12] [13] Formation of C radical intermediates in laboratory experiments is demonstrated by interception with thiols [10] or spin-trapping agents. [9, 14] C Radicals are purportedly involved in the alkylation of the heme when ferrous heme is used to induce cleavage of the peroxide in artemisinin and analogues. [15, 16] In the absence of trapping, the radical intermediates proceed to form stable end products, such as 14 and 15 from artemisinin ( Figure 1 and below), [9, 17, 18] which thereby serve as markers for the intercession of such radicals. The products are at the same oxidation level as the starting artemisinin; the Fe 2 + cation acts as a catalyst, as it is regenerated during their formation. [9] However, Fe 2 + is considered to engage in a second-order reaction with artemisinin under aqueous conditions. [19] The results nevertheless are better interpreted in terms of a catalytic reaction, first-order in artemisinin, being accelerated by the excess of the catalyst.
Whilst an artemisinin-heme interaction in one form or another within the food vacuole of the malaria parasite has been held responsible for antimalarial activity, [15, 16] the 'heme theory' itself is contentious. Artemisinins are vigorous inducers of CYP enzymes [20] in which the iron in the heme prosthetic group must cycle through the ferrous state in order to induce hydroxylation of the periphery of the molecule syn to the peroxide. This leaves the peroxide intact, as we first pointed out in 2001. [21] According to model studies, treatment of artemisinin with ferrous heme generates an artemisinin C radical, which undergoes an exceedingly rapid alkylation of the heme (of the order of a bond vibration). [22] As ligand exchange is required to free the putative C radical from the heme iron, [23] it cannot migrate away from the heme, and exclusively provides a hemeartemisinin adduct. Whilst the latter possesses antimalarial activity, this tends to be in the micromolar range in in vitro assays. [15, 24] It has been suggested that the exogenously applied adduct may not readily permeate the vacuolar membrane into the food vacuole. [15] Thus, this relatively weak activity may be ascribed to the redox properties of the ferric heme nucleus within the adduct enhancing oxidative stress within the cytosol of the parasite, as discussed below. Current data tend to indicate that the site of action of artemisinins is not within the food vacuole, [25] and it is established that artemisinins do not inhibit hemozoin formation. [26] However, assertions that artemisinins or artemisinin-heme adducts exert their effects by inhibiting hemozoin formation, [24] thereby allowing buildup of 'toxic' heme monomer in the food vacuole, or that heme is both the 'activating agent' and 'the target' of artemisinin continue to appear. [15, 16] The detection of radiolabeled artemisinin within artemisinin-heme adducts in minor amounts in urine or spleen extracts of infected mice administered with an excess of artemisinin, [27] whilst indicating unambiguous although minor sequestration of artemisinins by heme, are indicative of routes of excretion of metabolites, and cannot be taken at all as evidence of mechanism. Indeed, it is recognized that competitive sequestration of artemisinins by heme, as takes place in the foregoing experiment, attenuates their antimalarial activity. [28] The idea that iron is required for activation of artemisinins appears to rely in large measure on reports that iron chelators such as desferrioxamine B (DFO) antagonize the antimalarial activities of artemisinins in vitro. [29, 30] DFO is a hydrophilic chelating agent with exceptional affinity for Fe 3 + . The Fe 3 + chelate ferrioxamine B (FO) possesses a stability constant of 10 31 , which is 10 24 times greater than that of the Fe 2 + chelate. [31] Notably, DFO is parasiticidal at a concentration of~15 mm against P. falciparum, a level which is about 60-fold lower than that required for a cytostatic effect against mammalian cells. DFO affects late trophozoites and early schizonts, whereas artemisinins are effective parasiticidal agents against the early ring stage of the parasite. The antagonism cannot be reproduced Figure 1 . Fe 2 + -catalysed conversion of artemisinin 1 into "radical marker" products via seco C4 and C4 radicals held to be responsible for biological activity.
in vivo. [32] Antagonism in vitro may arise by removal of the bioavailable or 'labile' iron (as Fe 3 + ) required for parasite metabolism [33] or other effects. [34] FO is reduced by glutathione or ascorbic acid under aqueous conditions, providing that an Fe 2 + chelating agent is present. [35] DFO and FO markedly modulate intracellular damage caused by peroxides, [36] DFO acts as a free radical scavenger for hydroxyl and peroxyl radicals [37] and abolishes the in vivo antimalarial activity of alloxan, a non-peroxidic compound. [38] In relation to the basis of the antagonistic affect of iron chelators towards artemisinin, it was earlier assumed that iron chelators bind directly to heme to suppress activation of the artemisinin. [15, 29] As ferric heme is inert towards artemisinin [17] and DFO displays exquisite specificity for Fe 3 + , the proposals that DFO associates with the ferrous heme required for 'activation' of the artemisinin and that DFO 'abstracts' Fe 2 + from the heme [15] are implausible. An alternative explanation proffered was that the alkylated heme adduct "tends to release free iron". [24] Release of iron from the adducts under physiological conditions has not been demonstrated; the adducts are stable, requiring forcing conditions to remove the iron. [39] The inability of DFO to abstract Fe 3 + from hematin has been demonstrated, [40] and DFO has no effect on artemisinin-heme inhibition of erythrocyte membrane-bound ATPase activity. [41] Our own survey on the decomposition of artemisinin 1 with heme Fe 2 + , free Fe 2 + including Fe 2 + generated by reduction of Fe 3 + in situ with cysteine, in aqueous and nonaqueous solutions [17] coupled with a consideration of structure-activity relationships among artemisinin analogues, and the evident inability of certain active antimalarial cyclic peroxides to generate C radicals caused us to reject their feasibility as biologically significant intermediates. [13, 17, 21, 42] More recently, we identified inconsistencies between the reaction of artemisinins with ferrous heme and their decomposition by free Fe 2 + under aqueous conditions. [43] Our work was criticized on the grounds that some of the artemisinins, because of their presumed insolubility in the aqueous medium, cannot interact with the iron. [44] It was demonstrated that one of our aqueous Fe 2 + -inert artemisinins efficiently alkylated ferrous heme under aprotic conditions, which are drastically different to those in the food vacuole of the parasite, the presumed site of "heme activation" of the artemisinins. [23] However, 10-deoxoartemisinin 5 (Figure 2 ), which displays greater antimalarial activity than artemisinin, is rapidly decomposed by aqueous Fe 2 + , but not by aqueous ferrous heme, [23] and it has no effect on hemozoin formation. [26] Artemisinins, like the sesquiterpene thapsigargin (TG), are inhibitors of the malaria parasite sarco-/endoplasmic reticulum Ca 2 + (SERCA) ATPase. [45] Inhibition of SERCA orthologues of P. falciparum (PfATP6), P. vivax (PvSERCA), and P. berghei (PbSERCA) by artemisinins correlates with their ability to kill these parasites. [46] Specificity appears to be associated with residues lining the TG binding cleft of SERCAs, because altering a single amino acid in transmembrane helix 3 through an L263E mutation in PfATP6 decreases sensitivity to artemisinins. [46] That a single substitution elsewhere in the PfATP6 sequence segregates with the phenotype of increased IC 50 for artemether in parasites from patients would appear to corroborate the assignment of PfATP6 as a target for the artemisinins. [47] Artemisone 7 (Figure 2) , [48] a representative of the class of 10-amino-10-dihydroartemisinins, [43] in phase II trials cures malaria patients at one third the dose of the clinically used artesunate 3.
[ 49] Other aminoartemisinins such as 8 and 9 express exceptional activities in vivo against P. berghei in mice (sc ED 90 values: 8, 0.6 mg kg À1 ; 9, 0.35 mg kg À1 ; artesunate 3,
mg kg À1
). [48] Artemisone is an especially effective inhibitor of parasite SERCAs: K i PfATP6 7, 1.7 AE 0.6 nm (artemisinin 1, 169 AE 31 nm); K i PvSERCA 7, 0.072 AE 0.012 nm (1, 7.7 AE 4.9 nm). [46] Therefore, according to the Fe 2 + -activation model, artemisone and the other aminoartemisinins are required to generate C radicals which are especially adept at mediating their biological activities, presumably by alkylating the ATP6 site.
Thus, the advent of artemisone, with its well-defined physicochemical properties coupled with both its potent antimalarial activity and inhibition of PfATP6, provides a robust opportunity to probe the relationship between its Fe 2 + -mediated decomposition to putative C radicals and biological properties. 4-Oxo-TEMPO efficiently reacts with radicals formed during Fe 2 + -mediated decomposition of synthetic trioxolanes; the results indeed have been used as a basis for design of new trioxolane antimalarials. [50, 51] Therefore, it is expedient to scrutinize this construct by evaluating the ability of 4-oxo-TEMPO to trap the putative C radicals from artemisone and other artemisinin derivatives. We also examined the effects of DFO on PfATP6 inhibition and antimalarial activity of the artemisinins of Figure 2 , and the effect of ascorbic acid on the aqueous Fe 2 + -mediated decomposition of the artemisinin derivatives. Ascorbic acid antagonizes in vitro antimalarial activity of the clinically used artemisinins, [30, 52] but it is also a potent reductant for Fe 3 + to Fe 2 + in aqueous solutions, even where the former is associated with normally stable Fe 3 + chelates. [35, 53] Figure 2. Artemisinins 1-12 and synthetic trioxolane 13 [51] used in this study.
Results a. Ferrous iron mediated decomposition
i. Artemisinins 1-3
The decomposition of artemisinin 1, DHA 2, and artesunate 3 by ferrous sulfate in 1:1 acetonitrile/water at 20 8C during 24 h (method a), although examined elsewhere, [9, 17] was repeated herein under milder conditions in order to provide a comparison of results with our artemisinins. Structures of products and yields, including literature data from similar reactions conducted at 37 8C (method al), [9] are given in Table 1 . Ascorbic acid (method b) slightly enhanced the decomposition rates; reaction half-lives (Table 1) were determined from plots of decomposition of artemisinin as a function of time. Artemisinins 1 and 7 (below) were inert to an excess of ascorbic acid in the absence of iron. An accelerating affect of ascorbic acid on aqueous Fe 2 + -catalyzed reactions has not been reported previously, although its presence apparently results in the formation of minor amounts of other products. [18] DHA 2 with FeBr 2 in THF (method c) [8] [9] [10] 54] gave not the radical marker products 16 and 17, [9] but rather the tricarbonyl compound 18 as a single epimer and the 2-deoxyglycal 19. At room temperature, 18 underwent conversion into a mixture containing 25 % of a second epimer. The same mixture was obtained by thermolysis of DHA at 100 8C. [55] A mixture of 18 together with an isomer described as the C6 epimer was originally obtained by thermolysis of DHA at 190 8C. [56] However, epimerization is shown to occur at C1' and not at C6. [55] The identity of 19 was secured by dehydration of 2-deoxyDHA [2] with methanesulfonyl chloride and triethylamine in dichloromethane. Ferrous acetate in 1:1 acetonitrile/dichloromethane (method d), which effectively induces decomposition of synthetic trioxolanes such as 13, [50, 51] had little effect on DHA; approximately 72 % was recovered, together with small amounts of the tricarbonyl compound 18 and the furan 20.
ii. Artemisinins 5 and 6
Exposure of artemisinins 5 and 6 to ferrous sulfate/ acetonitrile/water gave the products and their yields as shown in Table 2 . Whereas 5 was efficiently decomposed, 6 is essentially inert. Ascorbic acid accelerated decomposition of the former, but had no effect on the latter. The tricarbonyl compound 26, a single epimer, emerges as the dominant product from 5 at the expense of the radical marker products 24 and 25 with FeBr 2 /THF. The reagent has also been reported previously to provide 26 and 28 from 5 (method cl, Table 2 ). [54] The tricarbonyl compound 26 was obtained as the sole product by heating 5 at 100 8C (method e, Table 2 ). Compound 27, obtained previously from 5 by a rearrangement driven by activation of the peroxide bridge by complexation with a Lewis acid, [57] likely arises in the present case via a similar event triggered by Fe 2 + or Fe 3 + . Ferrous acetate in 1:1 acetonitrile/dichloromethane gave the radical marker product 24 and the tricarbonyl compound 26.
iii. 10-Amino-10-dihydroartemisinins 7-12
With the exception of artemisone 7, the aminoartemisinins tended to be relatively inert under aqueous conditions (Table 3 ). However, ascorbic acid enhanced the decomposition of the benzylpiperazine derivative 8 and had a slight effect on the pyrimidylpiperazine derivative 9. With FeBr 2 /THF, the derivatives gave complex product mixtures from which only relatively small amounts of discrete decomposition products could be isolated. [51] gave only variable amounts of the products arising from the artemisinins alone (cf. Tables 1 and  3 ). Treatment of a 1:2 mixture of [b] d [b] 
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R =ÀNH-p-fluorophenyl a c [b] d [b] 11: 61, 37: www.chemmedchem.org 10-deoxoartemisinin 5 and 4-oxo-TEMPO with ferrous acetate (1.5 equiv) gave the radical-trapped product 42 (3 %), and the products of Table 2 . Artemisone provided the product 43 in 10 % yield. Treatment with ferrous acetate (3 equiv) of a 1:1:2 mixture of 5, 13, and 4-oxo-TEMPO provided 42 (3 %) and 44 (73 %) arising by entrapment of the seco-radical 45 from 13.
[51]
Thus, the inability of 4-oxo-TEMPO to intercept significant amounts of C radicals from the artemisinins is not due to an experimental artifact. Identification of 42 follows through a consideration of its spectroscopic data and general similarity with that of 24 ( Table 2 ). Compound 43 is characterized through its spectroscopic data (Experimental Section). In particular, the 1 H NMR spectrum indicates a cis-coupling of 2.9 Hz between H-10 and H-9. The genesis of this compound is discussed below.
c. Effect of desferrioxamine on biological properties
The effect of iron on PfATP6 inhibition was evaluated with desferrioxamine B (DFO) (Figure 3 ). Although DFO attenuates inhibition of PfATP6 by artemisinin 1 (500 nm), [45] ascorbic acid (AA) countered the effect of DFO, although AA alone had no effect on inhibition. Inhibition of PfATP6 by artesunate 3 (250 nm) and 10-deoxoartemisin 5 (100 nm), both rapidly decomposed by aqueous Fe 2 + (Tables 1  and 2 ), was attenuated by DFO. In contrast, DFO did not significantly suppress inhibition by the p-fluorophenyl derivative 6 (250 nm), artemisone 7 (5 nm), and the pyrimidylpiperazine derivative 9 (100 nm) ( Figure 3) . Significantly, compounds 6 and 9 are inert to aqueous Fe 2 + . The effect of DFO on antimalarial activity ( Figure 4 ) displays a provocative parallel with that on PfATP6 inhibition. DFO antagonized the antimalarial activities of the aqueous Fe 2 + -susceptible artesunate 3 and 10-deoxoartemisinin 5, although it had no observable effect on the aqueous Fe 2 + -resistant p-fluorophenyl derivative 6 or on artemisone 7.
The inhibition constant (K i ) for artesunate 3 against PfATP6 of 59.2 AE 7.3 nm and the IC 50 value of 6 AE 3 nm against P. falciparum (3D7) represents an approximate 10-fold difference in inhibitory potencies. Artemisone 7, with K i = 1.68 AE 0.63 nm and an IC 50 value of 0.6 AE 0.22 nm, demonstrates the smallest Figure 3 . Inhibition of PfATP6 by artemisinins (drug concentrations between EC 50 and EC 90 , black columns) and effect of desferrioxamine (DFO, 100 mm, gray columns) (data for artemisinin 1, 500 nm, from Ref. [45] ). Effect of ascorbic acid (AA, 100 mm, stippled column) on inhibition of PfATP6 by 1, and effect of a mixture of AA and DFO (each 100 mm, diagonals) in restoring inhibition of PfATP6 by 1; inhibition of PfATP6 by artesunate 3 (500 nm) and 10-deoxoartemisinin 5 (100 nm) and attenuation by DFO (100 mm, p < 0.001); inhibition of PfATP6 by 4-fluorophenylartemisinin 6 (250 nm, p = 0.8) and artemisone 7 (5 nm, p = 0.26) and relative lack of effect of DFO (p > 0.05). DFO has little effect on inhibition of PfATP6 by the pyrimidylpiperazine derivative 9 (100 nm, p = 0.6). Data (mean AE SEM) are from 6-10 experiments, except for 6 (n = 3); effects of DFO are assessed with Students (unpaired) t test. discrepancy (threefold). [46] However, the K i value of 277 AE 39 nm for 4-fluorophenylartemisinin 6 against PfATP6 is almost 200-fold higher than its corresponding IC 50 value (1.44 AE 0.28 nm, 3D7). Compound 6 is highly lipophilic (log P 5.59; cf. artemisone 7, log P 2.08) and is insoluble in water (< 1 mg L À1 ; cf. ar-
). [49] Therefore, competitive partitioning of 6 into the membrane lipids constituting the expression system used for the oocyte SERCA assays [58] will occur, decreasing the concentration of 6 available for binding. In contrast, selective concentration of artemisinins takes place in infected erythrocytes [59] wherein the more lipophilic artemisinins express very good activities in vivo against the malaria parasite. [48] Antimalarial activity of some of the artemisinins examined herein are given in Table 4 . According to this and other in vitro and in vivo data, [48] artemisone 7 ranks among the most active of all peroxidic antimalarials. [50] Trioxolane 13 possesses an IC 50 value of 4.5 nm against the K1 strain. [50, 51] Discussion a. Products of Fe 2 + -mediated decomposition
Before focusing on the wider implications of these results, we subdivide the products into type a arising via Fenton-like cleavage of the peroxide by Fe 2 + and intramolecular closure of the resulting C radicals with extrusion of Fe 2 + (cf. Figure 1 ), type b arising via formal peroxide cleavage and loss of formic acid, [55] and type c arising via reduction ( Figure 5 ). Formation of products aiii is favored by aqueous conditions, and products b and c by anhydrous conditions, becoming predominant for DHA 2 (Table 1) and for 5 and 6. Product types aii and bi arise from artemisinins bearing a leaving group at C10. Products a are formed in significant amounts under aqueous conditions from artemisinins 1-3, 5, and 7. The other aminoartemisinins tend to be less amenable to decomposition under aqueous conditions. In general, ferrous acetate under anhydrous conditions was relatively ineffective, and of the artemisinins examined, only 5 and 7 provided appreciable amounts of products. DHA 2 and the anilino artemisinin 11 are essentially inert.
The mode of formation of decomposition products has been exhaustively discussed, [9, 10, 17, 18, 54] and we confine our attention here to the products arising from the aminoartemisinins 7-12 ( Figure 6 ). When the decomposition provides intermediates 46 and 48 with a leaving group attached either directly to C10 as in 46 (formate), or via an electronically connected framework as in 48 (acetate), the amino group induces fragmentation to give the iminium ions 47 and 49, which will undergo hydrolysis to the carbonyl compounds on workup of the reaction mixture. In the case of the sulfamido artemisinin 10, the amine product of hydrolysis, the insoluble sulfamide (H 2 NSO 2 NH 2 ) is recovered. The formation of the radical-trapped product 43 diverts the seco-C4 radical away from the furan-forming pathway leading to 48. Entrapment with 4-oxo-TEMPO is followed by extrusion of acetate and Fe 3 + , and intramolecular cyclization of the pendant hydroxyl with the iminium group in intermediate 50 to give 43. This has the interesting consequence that the overall reaction will no longer be catalytic in Fe 2 + . Formation of the trapped product 42 from 10-deoxoartemisinin, which contains no electrofugal group, is consistent with the proposal of Figure 6 . The pathway leading via the C4 radical and epoxide 51 is disfavored under nonaqueous conditions; the inference is that the incipient O2 radical prefers to undergo cleavage to provide the tricarbonyl compound 46, a premise which is consistent with a non-concerted cleavage of peroxides to provide carbonyl compounds. [54, 55] The alternative pathway to the carbonyl compounds involves an Fe 2 + -(or Fe 3 + -) mediated heterolytic decomposition of the peroxide, formally a [2+2+2] cycloreversion, for which the thermal counterpart is demonstrated in the thermal decomposition of 10-deoxoartemisinin 5 ( Table 3) .
The formation of the products c may proceed via reduction of a hydroperoxide intermediate arising via ring opening [21] and re-closure of the resulting alcohol. [60] Ring opening of DHA to the hydroperoxide 52 (X = H, Y = O, Figure 7 ) is implicated in the facile formation of a rearranged peroxyhemiacetal from DHA. [55] In the present case, ring opening of DHA and the artemisinins 11 and 12 may be driven by protonation of the peroxide or by complexation with Fe 2 + . The hydroperoxides 52 on It is clear that under either aqueous or anhydrous conditions, Fe 2 + encumbered with oxygen ligands is less active as a decomposition catalyst than are ferrous halides. [9, 10, 17, 43, 61] The rate-determining step is displacement of the ligand, more facile for halide, by peroxide, to form a complex in which inner-sphere electron transfer from Fe 2 + to the peroxide initiates the Fenton-like cleavage. [62] The amino groups of the 10- aminoartemisinins will associate with Fe 2 + to form complexes that may either slow the rate of decomposition, or for steric reasons hinder formation of the complex between Fe 2 + and the peroxide. [48] The enhanced decomposition of the benzylpiperazine and pyrimidinylpiperazine derivatives 8 and 9 induced by ascorbic acid may be due to competitive generation of an ascorbic acid-Fe 2 + complex [63] that reduces the peroxide. Be that as it may, on the basis of the C radical hypothesis, the acceleration of the aqueous Fe 2 + decompositions by ascorbic acid is out of key with the antagonism of antimalarial activities reported for this reagent, [30, 52] given that the (faster) reactions leading to the radical marker products a imply an enhanced flux of 'bioactive' C radical intermediates.
The radical center in the seco-radical 45 from trioxolane 13, embedded in a rigid hydrocarbon skeleton, is amenable to efficient intermolecular trapping to provide 44. In contrast, the formation in poor yields of radical-trapped products 42 and 43 from artemisinins 5 and 7 indicates that internal quenching of the structurally relatively complex and flexible seco-C4 radical intermediates (cf. Figures 1 and 6 ) via extrusion of Fe 2 + to provide products ai-ii is facile. In addition, generation of the artemisinin C radicals competes with Fe 2 + -mediated cleavage of the peroxide to provide carbonyl compounds b (cf. Figure 6 ), a decomposition pathway which is not available to trioxolane 13. That is, the intercession of this manifold of intramolecular decomposition pathways of the artemisinins triggered by Fe 2 + implies that the concentration of the C radical intermediates available for an intermolecular reaction with a crucial biomolecule will be low indeed, even in the situation where the artemisinin may be bound in a protein cleft, such as the TG-sensitive cleft of PfATP6. This factor aside, we have already pointed out [13] that those elegantly constructed analogues of artemisinins lacking C3 and/or C4, [64] and a rearrangement product of DHA, which is incapable of reverting to DHA, [42, 55] are active antimalarials, even though formation of C radicals are not apparent for these substrates.
In light of the foregoing, the recent idea [65] that products of type ai may be taken as markers of the biological importance of the seco-C4 radical precursors (cf. Figures 1 and 6 ) is noteworthy. The formation of these compounds in limited yields under aqueous conditions, and the inability to effectively trap the C radical precursor with the optimal, although non-biological reagent-the stable radical 4-oxo-TEMPO-implies that in the intracellular environment, the likelihood of the C radical precursor damaging a vital biomolecule by whatever mechanism must be small. Finally, the successful trapping of C radical 45 by the stable O-centered radical cannot be used to support the assumption that such C radicals are the actual cytotoxic intermediates in biological systems. C Radicals associated with a saturated flexible framework are unsuited per se for alkylation of biomolecules. [13] Suffice it to say that they are reduced by thiols, as has been recorded in the artemisinin area, [10, 18] and react at a diffusion-controlled rate with oxygen. An inference that such radicals may react with oxygen has been made. [61] C Radicals are generated by treatment of oxaziridines with Fe 2 + , yet the compounds are either inactive or feebly active as antimalarials. [66] ii. Interpretation of the effects of Fe 2 + , ascorbic acid, and DFO on biological properties
The observations recorded herein, namely that ascorbate accelerates the decomposition and that DFO antagonizes the PfATP6 binding and antimalarial activities of the aqueous Fe 2 + -susceptible, but not that of the aqueous Fe 2 + -insusceptible artemisinins, are not easily reconciled with current dogma on the mechanism of action of artemisinin antimalarials. Furthermore, if the C radicals are not viable intermediates, then, if it is accepted that an interaction of the artemisinin with PfATP6 is a prerequisite to parasite death, a different kind of reactive intermediate from the artemisinin which irreversibly modifies the transporter or destroys a crucial endogenous substrate, such as a cofactor associated with the transporter, must be involved.
The Fe 2 + available for activation of the artemisinins within the parasitized erythrocyte is presumed to be associated with the extra-and intracellular labile iron pools containing redoxactive iron complexes, which are subject to scavenging by chelators, and which are responsible for mediating generation of reactive oxygen species (ROS) and modulating oxidative stress. [67, 68] Thus, those artemisinins 1, 3, and 5 susceptible to aqueous Fe 2 + -mediated decomposition may suffer competitive degradation in the aqueous extracellular medium or intracellular aqueous cytosolic compartments by the labile Fe 2 + . The antagonism of antimalarial activity by ascorbic acid is then ascribed to the greater concentrations of Fe 2 + generated by ascorbic acid enhancing this degradation. DFO both attenuates PfATP6 inhibition by the aqueous Fe 2 + -susceptible artemisinins and antagonizes their antimalarial activities, but has relatively little effect on the aqueous Fe 2 + -resistant artemisinins 6 and 9. This observation is not easily explained. However, DFO, via the Fe 3 + complex ferrioxamine (FO), likely sequesters and concentrates iron stores, probably in aqueous compartments in the cytosol. [35] Exposure to an endogenous reductant such as glutathione or ascorbate [35] may produce locally high concentrations of Fe 2 + that competitively destroy the susceptible artemisinins, but have little effect on the aqueous Fe 2 + -inert artemisinins 6 and 9. Ascorbic acid neutralizes the attenuating effect of DFO on inhibition of PfATP6 by 1 (Figure 3) because Fe 3 + is no longer available for sequestration by DFO. Alternatively, artemisinins may undergo ring opening to provide free hydroperoxides (cf. 52, Figure 7 ) in the intracellular environment. [17, 21, 42, 60] Such ring opening of artemisinin and DHA, the principle metabolite of the clinically used artemisinins artesunate 3 and artemether 4, occurs under mild conditions in the laboratory, [55, 60] although this has yet to be demonstrated for artemisinins bearing other groups at C10. In any event, ascorbate, DFO, or endogenous reductant in the aqueous intracellular environment will destroy the hydroperoxides derived from the aqueous soluble artemisinins, decreasing the amount of drug available for a parasiticidal effect.
Irrespective of the exact mode of attrition, 10-deoxoartemisinin 5, with an aqueous solubility of 294 mg L À1 , is highly susceptible to decomposition by aqueous Fe 2 + , and DFO attenuates its inhibition of PfATP6 and antagonizes antimalarial activi-ty. Artemisone 7, with its good physicochemical properties, is efficiently transferred to the target, [46] and the effect of DFO is less pronounced. The fluorophenyl derivative 6 and aminoartemisinins such as 8 are not readily decomposed by aqueous Fe 2 + ; that is, they cannot suffer competing degradation en route to the target. Thus, DFO does not overtly influence binding to PfATP6 or antimalarial activities of these compounds. It is of interest to note that 6 and other lipophilic aminoartemisinins generally display greater antimalarial activities (and higher toxicities) than do more polar derivatives. [4, 43, 48] These compounds will be less prone to enter the aqueous cellular compartments and will localize and migrate within lipophilic structures such as organelle membranes; that is, they are protected from adventitious decomposition. In common with the action of lipophilic hydroperoxides, biological activities will not be greatly impaired by the presence of iron chelators, which are unlikely to access iron in a lipophilic environment. [69] The antimalarial activities and their modulation by DFO, and the effect of artemisinins on the thapsigargin (TG)-sensitive SERCA ATP6 target have an intriguing parallel with the biological properties of structurally simple peroxides that cannot readily generate C radicals. This parallel in antimalarial activities has been brought out in a classical review of oxidant drugs and malaria. [70] tert-Butyl hydroperoxide (TBH) induces rapid reduction in parasitemia in mice infected with P. vinckei, whereas it has no effect on uninfected mice, [71] and is parasiticidal in vitro towards P. falciparum. [72] In relation to its effect on Ca 2 + transporters, TBH increases intracellular Ca 2 + levels in PC12 pheochromocytoma cells. Pretreatment with TG abolishes the effect of TBH, whereas pretreatment with TBH abrogates the TG-induced increase in Ca 2 + . [73] Hydrogen peroxide at micromolar concentrations is parasiticidal in vitro and in vivo against P. yoelii and in vitro against P. falciparum. [70] The effect of H 2 O 2 in modulating intracellular Ca 2 + levels is well known. [74] As one pertinent example, it increases cytosolic and mitochondrial Ca 2 + concentrations in pancreatic cells; pretreatment with TG inhibits the H 2 O 2 -induced changes. Thus, H 2 O 2 , like TBH, exerts an effect on TG-sensitive Ca 2 + ATP transporters in mammalian cells. [75] Artemisinins at micromolar levels induce apoptosis in mammalian cells by modulating cytosolic Ca 2 + levels, although the direct cause has yet to be pinpointed. [76] To summarize, the hallmark of oxidant stress as elicited by all peroxidic compounds is overt modulation of intracellular Ca 2 + flux [77] leading to apoptosis, such as may be effected by inhibition of the TGsensitive ATP transporter PfATP6 in the parasite.
Thus, a proper appreciation of the manner in which artemisinins, and apparently simple hydroperoxides, interact with the transporter becomes crucially important. In this respect, it is unclear how structurally diverse peroxides such as 10-deoxoartemisinin 5, the pyrimidinylpiperazine derivative 9, trioxolane 13 and its close relatives, [50, 78] and a steroidal tetroxane, [79] which possess antimalarial activities in vitro ranging from 1.5-11.4 nm may bind into the TG cleft to inhibit parasite PfATP6. For example, the trioxolane, OZ OZ277 (RBx6660) is two orders of magnitude less effective in inhibiting PfATP6 (K i = 7700 nm) than is artemisinin (K i = 79 nm), an interaction which is also apparently sensitive to DFO. [78] Compounding this quandary are the observations that replacement of residues lining the TG binding cleft in PfATP6 by orthologous residues affects the inhibition by artemisinin and artemisone, and that mammalian SERCAs are at least an order of magnitude less sensitive to these artemisinins. [46] Although artemisinin reduces mitochondrial inner membrane potential in a yeast model through irondependent generation of ROS, [80] it is unlikely our Fe 2 + -resistant artemisinins will elicit such an effect. The non-neurotoxic artemisone 7, unlike artemether or DHA, has no effect on mitochondrial membrane potential, on ROS levels, or on inhibition of the respiratory chain in neuronal cell lines. [81] Therefore, the proposal that artemisinins exert their antimalarial activity by interfering with mitochondrial function [80] is premature.
Conclusions
The PfATP6 inhibition and antimalarial mechanism is independent of reductive cleavage of the peroxide by Fe 2 + leading to C radicals. [12] The potent antimalarial activities of our aminoartemisinins are inconsistent with their demonstrably inefficient conversion into C radicals, which further, because of facile intramolecular quenching pathways, cannot be fruitfully intercepted. In contrast, the trioxolane 13 provides a good yield of a radical-trapped product, yet possesses lower antimalarial activity (higher IC 50 value). As an explanation for the antimalarial activity of artemisinins, or indeed of the biological activities of artemisinins at large, the C radical hypothesis is not feasible.
Artemisinins, trioxolane, and tetroxane analogues, as peroxide carriers, are capable of drastically influencing intracellular events, as has been established for hydrogen peroxide and alkyl hydroperoxides. As artemisinins have the peroxide encapsulated within a robust tricyclic scaffold, they are less prone to undergo adventitious decomposition such as reduction or Haber-Weiss chemistry characteristic of unprotected hydroperoxides. If binding to PfATP6 is a crucial step in the pathway to destruction of the malarial parasite, it needs to be established if this is associated with an irreversible chemical change in the cleft, or destruction of a crucial endogenous substrate such as a cofactor, which occurs because of the binding, and which has the consequence of inhibiting overall function of the transporter. The precise role of the peroxide remains to be defined. If an open hydroperoxide is involved, it can act as an electrophilic oxygenating agent, or provide hydroxyl or alkoxyl radicals now capable of reacting with biological substrates. [17, 21, 43, 60] It should be noted that the intercession of the Haber-Weiss chemistry leading to O-centered radicals is not necessarily dependent on the presence of metal ions. [82] Alternatively, the hydroperoxide or the intact peroxide may act as an electron acceptor (oxidant), for example, in disrupting a catalytic cycle involving the cofactor. [83] The important difference here is that it is the intrinsic reactivity of the peroxide which confers antimalarial activity, not the erratically derived and fickle C radicals.
The intraerythrocytic malaria parasite is in an environment which is oxidatively stressed. [70, 83, 84] Thus, enhanced levels of methemoglobin, of lipid peroxidation, increased intracellular flux of hydrogen peroxide and ROS, and other effects render intraerythrocytic parasites peculiarly susceptible to modulation of oxidative stress. Substantially lower quantities of artemisinins-on the order of nanomolar concentrations-are required to kill the intraerythrocytic parasite, whereas oxidatively unstressed mammalian cells require larger amounts of artemisinins-in the micromolar range-to elicit cytotoxic effects. [65, 85] Fe 2 + profoundly modulates oxidative stress in its own right. [67, 86] Thus, the enhancement of cytotoxicities of artemisinins in mammalian cells [87] by addition of Fe 2 + is unsurprising. At the proof stage of this manuscript, a publication appeared presenting details of an examination of the effects of DFO and the more lipophilic chelator deferiprone on the antimalarial activities of a series of peroxidic antimalarials. [88] The chelators were shown to antagonize the antimalarial activities of selected peroxides, including artemisone. It is important to note that the "antagonism" does not mean destruction of antimalarial activity. The drugs are still substantially antimalarial active in the presence of the chelators; therefore, extrapolation of the authors' interpretation of the role of the chelators implies that there must be a "non-iron" pathway of activation. The possibility of the chelators reacting with the artemisinins or putative peroxide intermediates aside, if one function of the chelators is to remove labile iron, this will alleviate oxidative stress, and more of the artemisinin is now required to kill the parasite, as explained in the preceding paragraph. Thus the data in reference [88] , including the use of normal nonproliferating human PBMC as a control, do not imply at all that peroxidic antimalarials have to react chemically with iron to exert their antimalarial effect.
Experimental Section
Artemisinin 1 and DHA 2 were purchased from the Kunming Pharmaceutical Corporation (PR China) or from Haphacen, Hanoi College of Pharmacy (Vietnam) and used without further purification. Artesunate 3 was prepared according to the Chinese procedure. [3] The other derivatives were prepared as previously described. [43, 48] 4-Oxo-TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy, free radical) was used as received from Sigma-Aldrich.
All reactions were carried out under an atmosphere of N 2 . The following solvents were dried prior to use: ethyl acetate from MgSO 4 , hexanes (CaCl 2 ), CH 2 Cl 2 (CaH), triethylamine (CaH and stored over KOH pellets), and tetrahydrofuran (sodium in benzophenone). TLC was performed with Merck Kieselgel 60 F 254 plates and visualized with UV light (254 nm) and/or heating after treatment with 5 % ammonium molybdate in 10 % concentrated H 2 SO 4 . Column chromatography was performed with Merck silica gel 60 (0.04-0.063 mm). 1 H and 13 C NMR spectra were obtained as solutions in CDCl 3 on a Varian Mercury spectrometer operating at 300 and 75 MHz, respectively. Melting points were carried out on a Leica Hot Stage DME E compound Microscope and are corrected. MS data were obtained on a Finnigan TSQ 7000 mass spectrometer (CI + , methane), on an API QSTAR high-performance triple-quadrupole time-of-flight (ToF) mass spectrometer with electrospray ionization, and on a Waters Micromass GCT premier ToF high-resolution mass spectrometer (CI + , methane). IR spectra were recorded either on a PerkinElmer PC 16 or a PerkinElmer Spectrum One spectrometer. Optical rotations were performed on a PerkinElmer model 241 spectrometer. Elemental analyses were obtained from MEDAC Ltd., Surrey (UK). O (4 mL) was added dropwise to a stirred solution of the artemisinin derivative (0.4 mmol) in CH 3 CN (4 mL) under N 2 at room temperature, and the mixture was stirred for 24 h. It was then extracted with CH 2 Cl 2 (3 20 mL) and the combined organic layer was washed with deionized H 2 O (20 mL). The organic layer was separated and dried (MgSO 4 ). After filtration and concentration of filtrate under reduced pressure, the amounts of unreacted starting material and the products in the crude product mixture were estimated by 1 H NMR spectroscopy of the product mixtures as described below. The components were also separated by chromatography with ethyl acetate/hexanes as eluent to give the unreacted artemisinin derivative and the decomposition products. Products were weighed and identified either by comparison with reported data, or if new, by spectroscopic methods as described below. Yields as given below refer to the amounts of starting material and products isolated from the reaction mixture. O (6 mL) was added dropwise to a stirred solution of the artemisinin derivative (0.6 mmol) in CH 3 CN (6 mL) under N 2 at room temperature. Aliquots (3.4 mL) of the reaction mixture were withdrawn (at 2, 3, 4, 6, and 10 h for Set I, and at 14, 18, and 24 h for Set II), followed by extraction with CH 2 Cl 2 (3 10 mL), and the organic layer in each case was washed with deionized H 2 O (10 mL). The organic layer was separated and dried (MgSO 4 ). After filtration and concentration of the filtrate under reduced pressure, the residue was taken into CDCl 3 containing 1,3,5-trimethoxybenzene (5 .0 mg) as an internal standard.
1) In vitro decomposition of artemisinin derivatives with

1
H NMR measurements were conducted by comparing the intensity of the aromatic signal in the standard at 6.08 ppm against the singlet due to H-12 in each of the artemisinins (artemisinin 1 5.86, artesunate 3 5.44, 4-fluorophenyl 6 5.55, artemisone 7 5.27, benzylpiperazine derivative 8 5.35, pyrimidinylpiperazine derivative 9 5.27, sulfamide 10 5.38, 4'-fluorophenylamino 11 5.41, 4'-fluorobenzylamino 12 5.27 ppm). As an independent check, starting material was also isolated in a pure state by chromatography, weighed, and constitution verified by spectroscopic analysis. In the case of the 10-deoxo compound 5, the signal due to H-12 (5.20 ppm) overlaps the signal of H-12 in the decomposition product 25 in the 1 H NMR spectra of the product mixtures. Therefore, the rate of decomposition of 10-deoxoartemisinin was followed by monitoring changes in peak intensities of the signal due to the methyl group at C3 (1.48 ppm) and H-9 (multiplet at 2.65 ppm) relative to the internal standard. The decomposition products were isolated by flash column chromatography with 20 % ethyl acetate in hexanes as eluent, weighed, and each identified as described below. The procedure was repeated by running the decomposition reactions in the presence of ascorbic acid (1.0 equiv). Rates of decomposition of selected artemisinins were plotted against time, and half-lives were obtained from the plots. c) FeBr 2 : The artemisinin (1.1-1.4 mmol) and anhydrous FeBr 2 (0.5 equiv) in THF under N 2 were allowed to stir for 45 min at room temperature. The reaction mixture was quenched with saturated aqueous sodium hydrogen carbonate (100 mL). The aqueous layer was extracted with ethyl acetate (3 30 mL). The organic layer was separated and washed with saturated aqueous NH 4 Cl (3 30 mL) . The combined organic layer was dried (MgSO 4 ). After filtration and concentration of the filtrate under reduced pressure, the products were separated by chromatography with ethyl acetate/hexanes as eluent.
d) FeA C H T U N G T R E N N U N G (OAc) 2 and 4-oxo-TEMPO: A solution of anhydrous FeA C H T U N G T R E N N U N G (OAc) 2 (1.5 equiv) in CH 3 CN (8 mL) was added to a stirred solution of artemisinin derivative (1.3-2.0 mmol) and 4-oxo-2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO, 2.0 equiv) in CH 2 Cl 2 (8 mL) under N 2 at room temperature. After 24 h, the reaction mixture was quenched with saturated aqueous sodium hydrogen carbonate (16 mL). The aqueous layer was extracted with ethyl acetate (3 32 mL). The organic layer was separated and washed with saturated aqueous NH 4 Cl (2 32 mL). The combined organic layer was dried (MgSO 4 ). After filtration and concentration of the filtrate under reduced pressure, the products were separated by chromatography with ethyl acetate/hexanes as eluent.
2) SERCA assay in oocyte preparations
Assays were conducted after microinjection of cRNA as previously described.
[89] Ca 2 + ATPase activity was measured (pCa 5.5, 10 mg total protein, 25 8C) using a coupled enzyme assay as described, and K i refers to apparent half-maximal inhibition of Ca 2 + -dependent ATPase activity. The effects of DFO (100 mm) on inhibition of PfATP6 activity were assessed using concentrations of inhibitors that are close to their K i values.
3) Parasite culture and isobologram analysis
Parasites (clone 3D7, D10, and W2) were cultured using standard techniques. IC 50 2-DeoxyDHA 35, mp: 142-144 8C, was prepared by catalytic hydrogenation of DHA as described. [2] 2-DeoxyDHA (500 mg, 1.87 mmol) in CH 2 Cl 2 (10 mL) under N 2 was treated sequentially with methanesulfonyl chloride (0.35 mL, 2.24 mmol, 1.2 equiv) and triethylamine (0.39 mL, 2.80 mmol, 1.5 equiv) at room temperature. After 1.5 h, the mixture was treated with saturated NH 4 Cl (10 mL) and extracted with CH 2 Cl 2 (3 10 mL). The combined organic layer was dried (MgSO 4 ). Filtration and concentration of the filtrate under reduced pressure left a pale-yellow residue, which on chromatography with ethyl acetate/hexanes (15:85) gave the 2-deoxyglycal 19 (370 mg, 79 %), identical with the sample obtained from Fe 2 + decomposition of DHA, and a second uncharacterized dimeric product (64.8 mg, 6.7 %).
4) Decomposition of artemisinins
The tricarbonyl compound 18 was obtained as a single epimer when it was freshly isolated: 23 (m, 3 H), 1.16 (s, 3 H), 1.17 (s, 3 H), 1.24-1.35 (m, 1 H), 1.29  (s, 3 H), 1.32 (s, 3 H), 1.40-1.51 (m, 1 H) , the 1,2,4-trioxolane 13 [51] (211.3 mg, 0.8 mmol), and 4-oxo-TEMPO (544.8 mg, 2.0 equiv) in CH 3 CN/CH 2 Cl 2 (1:1, 12 mL) under N 2 was stirred at room temperature for 24 h. It was quenched with saturated aqueous sodium hydrogen carbonate (12 mL) followed by acetic acid (3 mL). The aqueous layer was extracted with ethyl acetate (3 24 mL). The organic layer was separated and washed with saturated aqueous NH 4 Cl (2 24 mL). Filtration and concentration of the filtrate under reduced pressure gave a residue which was redissolved in ethyl acetate (2 mL). The organic layer was washed with saturated aqueous sodium hydrogen carbonate (3 8 mL). The organic layer was separated as 'organic layer A'. The combined aqueous layer was acidified with 2 m aqueous H 2 SO 4 . The acidified aqueous layer was extracted with ethyl acetate (3 60 mL). The combined organic layer was dried (MgSO 4 ). Filtration and concentration of the latter under reduced pressure gave solely 44, a white solid (196.3 mg, 73 %), with data as previously described: [51] 1 H NMR: d = 1.14 (s, 6 H), 1.14-1. 35 [55] pale-yellow viscous oil; The enamine 38 (326.9 mg, 0.95 mmol) and sodium periodate (835.8 mg, 4.1 equiv) were stirred in CCl 4 (4 mL). CH 3 CN (4 mL) was added followed by H 2 O (6 mL). The resulting mixture was stirred at 0 8C while rutheniumA C H T U N G T R E N N U N G (III) chloride hydrate (4.4 mg, 0.022 equiv) was added slowly. After 3 h, the reaction mixture was poured into CH 2 Cl 2 (20 mL Keywords: artemisinins · artemisone · PfATP6 · radicals · reactive oxygen species
